← Eichor
Study identifier: NCT07642674 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

The Effect of Intravenous Dexketoprofen on the Severity and Incidence of Rebound Pain

Condition: Postoperative Pain · Pain Management · Rebound Pain  ·  Sponsor: Eskisehir Osmangazi University

PhaseNA
Planned participants66
Who can joinAll sexes, 18 Years to 70 Years
Healthy volunteersNo

About this study

Orthopedic shoulder surgeries are associated with severe postoperative pain, particularly within the first 24-48 hours after surgery. In postoperative pain management, single or continue interscalene brachial plexus blocks, acetaminophen, nonsteroidal anti-inflammatory drugs (NSAIDs), and opioids administered as needed are commonly used as components of multimodal analgesia. Rebound pain is defined as severe postoperative pain (VAS ≥ 7) occurring within the first 24 hours after resolution of the block. It is considered an adverse effect of regional anesthesia and typically develops 8-12 hours after a single-shot nerve block. Risk factors for rebound pain include pre-existing pain, female sex, younger age, bone surgery, lack of intraoperative dexamethasone administration, and inadequate analgesia. The primary objective of this study is to evaluate the effect of intravenous dexketoprofen administered during the postoperative period on the incidence and severity of rebound pain in patients undergoing shoulder surgery with interscalene brachial plexus block

This description comes directly from the study's public registry record.

Talk to the study team

Çağla Uzalp  ·  02222392979  ·  caglauzalp@gmail.com

Meryem Onay  ·  02222392979  ·  dr.meryemonay@hotmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Eskisehir Osmangazi Universıty Faculty of MedicineEskişehir, Odunpazarı, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07642674